ANN ARBOR STAGE III NON-HODGKIN LYMPHOMA
Clinical trials for ANN ARBOR STAGE III NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE III NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE III NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test new Two-Pronged attack on tough cancers
Disease control OngoingThis early-stage study is testing a new combination of drugs for people with advanced solid tumors or non-Hodgkin lymphoma that has spread. The main goal is to find the safest and most effective dose by combining an experimental drug called veliparib with standard chemotherapy dr…
Matched conditions: ANN ARBOR STAGE III NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Scientists test drug combo to attack tough lymphoma
Disease control OngoingThis study tested adding a new drug called vorinostat to standard chemotherapy (R-CHOP) for people newly diagnosed with an advanced type of lymphoma called diffuse large B-cell lymphoma (DLBCL). The first goal was to find a safe dose of vorinostat to combine with chemo. The secon…
Matched conditions: ANN ARBOR STAGE III NON-HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for kids with tough cancers: treatment guided by tumor genetics
Disease control OngoingThis study is testing a personalized approach for children and young adults with advanced cancers that have come back or stopped responding to standard treatments. Doctors first test the genetic makeup of a patient's tumor to look for specific changes. If a matching change is fou…
Matched conditions: ANN ARBOR STAGE III NON-HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC